As of 2025-05-28, the Intrinsic Value of Roche Holding AG (ROG.SW) is 310.62 CHF. This ROG.SW valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 260.90 CHF, the upside of Roche Holding AG is 19.10%.
The range of the Intrinsic Value is 200.96 - 658.72 CHF
Based on its market price of 260.90 CHF and our intrinsic valuation, Roche Holding AG (ROG.SW) is undervalued by 19.10%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 200.96 - 658.72 | 310.62 | 19.1% |
| DCF (Growth 10y) | 223.79 - 674.68 | 332.67 | 27.5% |
| DCF (EBITDA 5y) | 145.11 - 218.74 | 179.52 | -31.2% |
| DCF (EBITDA 10y) | 175.99 - 263.12 | 215.49 | -17.4% |
| Fair Value | 51.14 - 51.14 | 51.14 | -80.40% |
| P/E | 205.99 - 274.15 | 246.77 | -5.4% |
| EV/EBITDA | 164.57 - 265.33 | 230.36 | -11.7% |
| EPV | 205.70 - 309.85 | 257.78 | -1.2% |
| DDM - Stable | 108.89 - 428.21 | 268.55 | 2.9% |
| DDM - Multi | 186.13 - 511.55 | 266.62 | 2.2% |
| Market Cap (mil) | 211,133.33 |
| Beta | 1.17 |
| Outstanding shares (mil) | 809.25 |
| Enterprise Value (mil) | 238,812.33 |
| Market risk premium | 5.10% |
| Cost of Equity | 6.36% |
| Cost of Debt | 4.25% |
| WACC | 5.95% |